Not Found

The requested URL index.php was not found on this server.

Apache/2.2.22 (Linux) Server at Port 80
1 Day 4 | Nexus 2019
Home Day 4

Day 4

Extended-Release Oral Suspension Amphetamine Reduces ADHD Symptoms with Rapid Onset and Extended Duration

A new study has found Dyanavel® XR (Amphetamine Extended-Release Oral Suspension; AMPH EROS) to be effective in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) with...

A Review of Alternative Payment Models and their Impact on Health Care

The current U.S. drug-reimbursement model is built on rebates, but these rebates often don’t address key problems, according to a presentation from Jane Barlow,...

Continued Drug Shortages and their Effects on Patient Care

A presentation given by Matthew Grissinger, RPh, FISMP, FASCP, at AMCP Nexus 2019 highlighted continued drug shortages and how they compromise patient care. The presentation...

New Drug Addresses Unmet Medical Need in Atopic Dermatitis Patients

Recent research presented at AMCP Nexus 2019 indicated that dupilumab may address a significant unmet medical need in patients with atopic dermatitis (AD). Atopic dermatitis...